Before Brands™, Inc. Revolutionizes Approach to Food Allergy Risk with the Launch of SpoonfulOne™ for Infants and … – Business Wire (press release)

MENLO PARK, Calif.–(BUSINESS WIRE)–Before Brands™, Inc., a science-based consumer products company, is
announcing its first product: SpoonfulOne™ Daily Food Mix-In, a dietary
supplement designed for children who do not have a food allergy to help
their bodies get to know and stay accustomed to the foods responsible
for 90 percent of food allergies. This new powder blend is a practical
way for parents to educate their child’s immune system once a day and
align with current feeding guidelines. SpoonfulOne is inspired by
studies demonstrating that the risk of a food allergy may be reduced by
consistent, early inclusion of small amounts of that food in the diet.

Developed based on the patented formula of a pediatrician, allergist and
mother of five, SpoonfulOne is made of gentle, measured portions of all
the foods most commonly associated with food allergy risk, including
peanut, milk, tree nuts, egg, fish, shellfish, wheat, soy and sesame
seeds, along with 400 IU of vitamin D for immune balance. Packaged in
pre-measured, single serve packets, SpoonfulOne powder can be easily
stirred into cereal, pureed fruits, mashed vegetables and more. Children
without a diagnosed food allergy can start SpoonfulOne any time. For
infants, parents can begin incorporating SpoonfulOne as soon as the
child is safely eating solid foods. And although it is better to include
the diversity of foods contained in SpoonfulOne in the diet early, it is
never too late to start incorporating small amounts of potential
allergens into the diet, as long as your child has not acquired a food

The latest research shows it is important to incorporate potentially
allergenic foods, early and consistently, in children’s diets,” said
Ashley Dombkowski, Before Brands Co-founder and CEO. “Our team of
experts developed SpoonfulOne to be balanced, inclusive and gentle so
that parents can have a practical way to apply this strategy.”

Food allergies are a growing problem affecting an estimated 6 million
children in the United States, or about two kids per classroom. Recent
research indicates that eating a small amount of potentially allergenic
food early and consistently may reduce the risk of developing an allergy
to that food. Leading organizations are taking notice and reversing old
recommendations in favor of guidelines that promote the importance of
early and consistent long-term inclusion.

  • 2013: The American Academy of Allergy, Asthma & Immunology:
    Recommends that healthy babies begin eating foods from all commonly
    allergenic food categories around 4-6 months of age.
  • 2015: Learning Early About Peanut (LEAP) Study, New
    England Journal of Medicine: The landmark study showed that the
    inclusion of a potentially allergenic food (peanut) in the diet
    reduced the risk of an allergy to that food by 80 percent if fed early
    and consistently for the first 5 years of life.
  • 2016: The Enquiring About Tolerance (EAT) Study, New England
    Journal of Medicine: The widely-cited study demonstrated that
    introducing a diverse set of potential allergens (wheat, dairy, egg,
    peanut, fish and sesame) in infants’ diets was safe. Although it was
    difficult for participants to adhere to the regimen, among those who
    did, the risk of any food allergy was reduced by two-thirds.
  • 2017: The American Academy of Pediatrics and National Institutes of
    : Published new guidelines recommending early, active
    inclusion of peanut protein in infants’ diets.
  • 2017: The Food and Drug Administration: Formally issued a
    Qualified Health Claim linking early peanut introduction to reduced
    risk of developing a peanut allergy.

The risk of developing food allergies is often a topic of concern,
confusion and anxiety for parents, especially as they begin the joyful
practice of feeding their babies solid food,” said Dr. Wendy Sue
Swanson, pediatrician, Chief Medical Officer, Before Brands, Inc. and
Chief of Digital Innovation, Seattle Children’s Hospital. “While they
are rightfully concerned about peanut allergies, many families don’t
know that 77 percent of people with a food allergy are allergic to
something other than peanut. I’m passionate about helping families
understand the new science guiding introduction of potential allergens
early and consistently to babies and toddlers. And I’m thrilled
SpoonfulOne makes it easy for busy parents to do so on a daily basis.”

The safety and tolerability of SpoonfulOne were investigated in a
randomized, blinded, placebo-controlled nationwide study in more than
700 healthy infants led by independent investigator and pediatrician,
Dr. Jane Holl, at Northwestern University. The study was entitled the
Introduction and maintenance of early adaptive training protein blends
in support of infant nutritional goals: safety and acceptability” study
(The IM EATING study). Results of this study have been accepted for
poster presentation as part of the European Academy of Allergy and
Clinical Immunology’s 5th Pediatric Allergy and Asthma Meeting October
26-29th, 2017.

In August of this year, the U.S. Patent and Trademark Office issued US
Patent No. 9,731,003 covering the SpoonfulOne formula. The company also
has a portfolio of additional patents pending that cover its technology.

To support the development and launch of SpoonfulOne, notable allergy
experts, physicians and scientists have joined the Before Brands
Scientific Advisory Board. Members include:

  • Dr. Katie Allen, Pediatric Allergist, Royal Children’s
    Hospital, Murdoch Children’s Research Institute, University of
  • Dr. Eugene Bauer, former Dean of Stanford University School of Medicine
  • Dr. Ruchi Gupta, Associate Professor of Pediatrics and Medicine,
    Northwestern University Feinberg School of Medicine, Ann & Robert H.
    Lurie Children’s Hospital of Chicago
  • Dr. David Hill, Pediatrician & Associate Editor of Caring for
    Your Baby and Young Child: Birth to Age 5
    , to be published by the
    American Academy of Pediatrics in 2019
  • Dr. Stephen Tilles, Allergist and 2017 President of the American
    College of Allergy, Asthma and Immunology
  • Dr. Christopher T. Walsh, Stanford University Department of Chemistry.
    Formerly of Harvard University, MIT and Dana Farber Cancer Institute

SpoonfulOne is made responsibly in accordance with the FDA’s Good
Manufacturing Practices for dietary supplements. It is available via
monthly subscription at
for between $2-$3 per day. Parents of high risk children, like those
with severe eczema, should talk to their pediatrician.

About Before Brands™, Inc.

Before Brands is a science-based health and wellness company dedicated
to bringing innovative nutritional products directly to families. Our
product development builds on a growing body of evidence in support of
nutritional strategies that include potentially allergenic foods as a
regular part of a healthy diet. The Company’s first line of products:
SpoonfulOne™, includes a patented blend of real food proteins and
vitamin D designed to help provide children with gentle and consistent
immune system support, before foods become allergens. SpoonfulOne™ is
based on intellectual property developed by Dr. Kari Nadeau, Director of
the Sean N. Parker Center for Allergy and Asthma Research and Stanford
University, and licensed to Before Brands™ on a global, exclusive basis.
Before Brands is a member of the Council for Responsible Nutrition.

We Nourish Possibilities™. Learn more about Before Brands™ and
SpoonfulOne™ at


Write a Reply or Comment:

Your email address will not be published.*